Teva Pharmaceutical Finance Netherlands III BV

CUSIP: 88167AAR2 Class: Corporate Bond - Foreign US$

Pacer Advisors, Inc.'s Holding History (CIK: 0001616667)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 75,000 Value ($000) $86 Avg Close — Range —
Q3 2025
Shares 22,000 Value ($000) $25 Avg Close — Range —
Q2 2025
Shares 75,000 Value ($000) $85 Avg Close — Range —
Q1 2025
Shares 43,000 Value ($000) $48 Avg Close — Range —
Q4 2024
Shares 85,000 Value ($000) $95 Avg Close — Range —
Q2 2024
Shares 82,000 Value ($000) $91 Avg Close — Range —
Q1 2024
Shares 117,000 Value ($000) $128 Avg Close — Range —
Q4 2023
Shares 117,000 Value ($000) $128 Avg Close — Range —
Q3 2023
Shares 117,000 Value ($000) $121 Avg Close — Range —
Q2 2023
Shares 117,000 Value ($000) $122 Avg Close — Range —